Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devin S McDougald

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Stem Cell Investigation|November 22, 2016
Personalized models reveal mechanistic and therapeutic insights into CEP290-associated Leber congenital amaurosisDevin S McDougald, Eric Kmiec, Jason A Mills
Ear and Hearing|August 29, 2014
Gene therapy for sensorineural hearing lossWade W Chien, Elyssa L Monzack, Devin S McDougald, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2019
AKT3 Gene Transfer Promotes Anabolic Reprogramming and Photoreceptor Neuroprotection in a Pre-clinical Model of Retinitis PigmentosaDevin S McDougald, Tyler E Papp, Alexandra U Zezulin, et al.
The Laryngoscope|April 21, 2015
Cochlear gene transfer mediated by adeno-associated virus: Comparison of two surgical approachesWade W Chien, Devin S McDougald, Soumen Roy, et al.
Investigative Ophthalmology & Visual Science|March 2, 2018
SIRT1 and NRF2 Gene Transfer Mediate Distinct Neuroprotective Effects Upon Retinal Ganglion Cell Survival and Function in Experimental Optic NeuritisDevin S McDougald, Kimberly E Dine, Alexandra U Zezulin, et al.
Nature Communications|January 27, 2019
AAV2.7m8 is a powerful viral vector for inner ear gene therapyKevin Isgrig, Devin S McDougald, Jianliang Zhu, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Clinically relevant AAV8- <i>PEX1</i> gene therapy preserves retinal integrity and function long-term in a murine model of Zellweger spectrum disorderSamy Omri, Erminia Di Pietro, Devin S McDougald, et al.
Molecular Therapy. Nucleic Acids|September 10, 2018
Spliceosome-Mediated Pre-mRNA trans-Splicing Can Repair CEP290 mRNAScott J Dooley, Devin S McDougald, Krishna J Fisher, et al.
Molecular Therapy. Methods & Clinical Development|April 27, 2019
CRISPR Activation Enhances <i>In Vitro</i> Potency of AAV Vectors Driven by Tissue-Specific PromotersDevin S McDougald, Thu T Duong, Katherine C Palozola, et al.
Biomolecules|June 24, 2022
Selective Upregulation of SIRT1 Expression in Retinal Ganglion Cells by AAV-Mediated Gene Delivery Increases Neuronal Cell Survival and Alleviates Axon Demyelination Associated with Optic NeuritisAhmara G Ross, Brahim Chaqour, Devin S McDougald, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Stem Cell Investigation|November 22, 2016
Personalized models reveal mechanistic and therapeutic insights into CEP290-associated Leber congenital amaurosisDevin S McDougald, Eric Kmiec, Jason A Mills
Ear and Hearing|August 29, 2014
Gene therapy for sensorineural hearing lossWade W Chien, Elyssa L Monzack, Devin S McDougald, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2019
AKT3 Gene Transfer Promotes Anabolic Reprogramming and Photoreceptor Neuroprotection in a Pre-clinical Model of Retinitis PigmentosaDevin S McDougald, Tyler E Papp, Alexandra U Zezulin, et al.
The Laryngoscope|April 21, 2015
Cochlear gene transfer mediated by adeno-associated virus: Comparison of two surgical approachesWade W Chien, Devin S McDougald, Soumen Roy, et al.
Investigative Ophthalmology & Visual Science|March 2, 2018
SIRT1 and NRF2 Gene Transfer Mediate Distinct Neuroprotective Effects Upon Retinal Ganglion Cell Survival and Function in Experimental Optic NeuritisDevin S McDougald, Kimberly E Dine, Alexandra U Zezulin, et al.
Nature Communications|January 27, 2019
AAV2.7m8 is a powerful viral vector for inner ear gene therapyKevin Isgrig, Devin S McDougald, Jianliang Zhu, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Clinically relevant AAV8- <i>PEX1</i> gene therapy preserves retinal integrity and function long-term in a murine model of Zellweger spectrum disorderSamy Omri, Erminia Di Pietro, Devin S McDougald, et al.
Molecular Therapy. Nucleic Acids|September 10, 2018
Spliceosome-Mediated Pre-mRNA trans-Splicing Can Repair CEP290 mRNAScott J Dooley, Devin S McDougald, Krishna J Fisher, et al.
Molecular Therapy. Methods & Clinical Development|April 27, 2019
CRISPR Activation Enhances <i>In Vitro</i> Potency of AAV Vectors Driven by Tissue-Specific PromotersDevin S McDougald, Thu T Duong, Katherine C Palozola, et al.
Biomolecules|June 24, 2022
Selective Upregulation of SIRT1 Expression in Retinal Ganglion Cells by AAV-Mediated Gene Delivery Increases Neuronal Cell Survival and Alleviates Axon Demyelination Associated with Optic NeuritisAhmara G Ross, Brahim Chaqour, Devin S McDougald, et al.
Pageof 2